Hot Watch List: Merck & Co. Inc. (NYSE:MRK), Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), Lazard Ltd. (NYSE:LAZ), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), WESCO International (NYSE:WCC)

Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 27.00% and weekly performance is 0.49%. On last trading day company shares ended up $57.95. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is -1.50%. On 8 July, Merck & Co. Inc. (NYSE:MRK) and Allergan plc (AGN) released that they have signed into an contract under which Allergan will purchase the exclusive worldwide rights to Merck’s investigational small molecule oral calcitonin gene-related peptide receptor antagonists, which are being developed for the treatment and prevention of migraine.

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares advanced 14.45% in last trading session and ended the day at $13.62. MRNS return on assets is -44.50%. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) quarterly performance is 50.25%. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) has commenced a clinical trial to test the effect of a synthetic form of the neurosteroid allopregnanolone called ganaxolone as a potential means of treating the condition.

On 10 July, Lazard Ltd. (NYSE:LAZ) shares advanced 2.26% and was closed at $53.95. LAZ EPS growth in last 5 year was 31.30%. Lazard Ltd. (NYSE:LAZ) year to date (YTD) performance is 11.42%. On 1 July, Lazard Asset Management LLC, a subsidiary of Lazard Ltd (NYSE:LAZ) announced the launch of three new mutual funds: the Lazard International Equity Advantage Portfolio (Institutional: IEAIX; Open: IEAOX), the Lazard Emerging Markets Equity Advantage Portfolio (Institutional: LEAIX; Open: LEAOX), and the Lazard Managed Equity Volatility Portfolio (Institutional: MEVIX; Open: MEVOX).

On 10 July, Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) shares increased 1.67% and was closed at $7.92. ARIA EPS growth in last 5 year was -0.20%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) year to date (YTD) performance is 15.28%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) was upgraded by analysts at Vetr
from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors.

WESCO International Inc. (NYSE:WCC) shares decreased -0.20% in last trading session and ended the day at $66.47. WCC Gross Margin is 20.30% and its return on assets is 5.60%. WESCO International Inc. (NYSE:WCC) quarterly performance is -3.96%.WESCO International Inc (NYSE:WCC) will announce second quarter 2015 earnings on Thursday, July 23, 2015, before the opening of the New York Stock Exchange. The Company will host a conference call at 11:00 A.M. Eastern Time that day to discuss the earnings results.

Leave a Reply

Your email address will not be published. Required fields are marked *